Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Organovo Holdings Inc.
Headquarters: San Diego, CA, United States of America
Website: http://www.organovo.com
Year Founded: 2007
Status: Public
Industry Sector: HealthTechnology
CEO: Keith Murphy
Number Of Employees: 20
Enterprise Value: $7,912,270
PE Ratio: -0.19
Exchange/Ticker 1: NASDAQ:ONVO
Exchange/Ticker 2: N/A
Latest Market Cap: $3,335,500
BioCentury | Mar 4, 2025
Deals
Kyorin picks Novartis amid innovative push; Abbvie taps Gubra for obesity: Deals Report
Plus: Hummingbird/Callio, Bridgene/Takeda, Magnet/Lilly, Gensaic/Novo, and more
BioCentury | Mar 1, 2022
Management Tracks
Jones leaving BMS to become CMO of Cullinan
Plus Singleton to join Bioventus as CFO, and updates from Noema, Lycia, Avidity and more
BioCentury | Jan 8, 2020
Company News
Management tracks: Fred Hutch taps BMS CSO Lynch; plus GSK, Rubius, Provention, Antengene, Revitope, Compugen, Wellington, Adamas, Arcturus and Turnstone
BioCentury | Oct 3, 2019
Company News
Oct. 2 Company Quick Takes: Merck, Immunovant, PureTech-Ariya, Viscient-Organovo and Durect
BioCentury | May 30, 2019
Company News
May 30 Company Quick Takes: Unity in-licenses protein for cognitive decline, plus Astellas, Organovo, Iovance
Items per page:
1 - 10 of 34